Gala Biotech gala.com


Public lists: Pharma Startups (4732)

Gala Biotech (Acquired by Cardinal Health - (NYSE: CAH)) developed a portfolio of protein expression technologies in mammalian cells. These systems have applications ranging from early development protein screening to large-scale pharmaceutical manufacturing.

Gala Biotech (Acquired by Cardinal Health - (NYSE: CAH)) developed a portfolio of protein expression technologies in mammalian cells. These systems have applications ranging from early development protein screening to large-scale pharmaceutical manuf...Show all

Company (Acquired)

Phone: 608-824-9920

Fax: 608.824.9930

8137 Forsythia Street

Middleton, 53562
Wisconsin, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Gala Biotech $13.8M Oct 14, 2003
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Gala Biotech Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 4 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

PlantForm Corporation

Guelph, Ontario, Canada
Alive / ActivePlantForm Corp is a new company focused on providing low cost therapeutic drugs for the improvement of quality of life. Established in early 2008 the company will use technology licensed from the University of Guelph to manufacture antibody and protein drugs in tobacco plants. The company's first product will be a biosimilar version of the breast cancer drug Herceptin. The world market in 2007 for this product was $1.7 billion and is anticipated to plateau at $3 billion in 2014 when PlantForm's ...Show allLogin to see details

Quintessence Biosciences

Madison, Wisconsin, United States
Alive / ActiveQuintessence Biosciences is a biopharmaceutical company focused on development of-based therapeutics as anti-cancer agents. The Company's products are based on the EVade Ribonuclease Technology which allows for the engineering of human proteins (ribonucleases) for the treatment of human diseases.Login to see details
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)